{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:03:11Z","timestamp":1791478991625,"version":"4.3.4"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"CNCS Romania - project","award":["PN-II-ID-PCE-2011-3-0731"],"award-info":[{"award-number":["PN-II-ID-PCE-2011-3-0731"]}]},{"name":"Sectoral Operational Programme for Human Resources Development"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["POSDRU 159\/1.5\/S\/136893"],"award-info":[{"award-number":["POSDRU 159\/1.5\/S\/136893"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/jcpt.12180","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T09:54:52Z","timestamp":1400666092000},"page":"535-540","source":"Crossref","is-referenced-by-count":20,"title":["A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers"],"prefix":"10.1155","volume":"39","author":[{"given":"C.","family":"Briciu","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy; Department of Clinical Pharmacy; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Neag","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Pharmacology, Toxicology and Clinical Pharmacology; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Muntean","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Department of Pharmaceutical Technology and Biopharmaceutics; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vlase","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Department of Pharmaceutical Technology and Biopharmaceutics; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bocsan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Pharmacology, Toxicology and Clinical Pharmacology; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buzoianu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Department of Pharmacology, Toxicology and Clinical Pharmacology; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Gheldiu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Department of Pharmaceutical Technology and Biopharmaceutics; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Achim","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Department of Pharmaceutical Technology and Biopharmaceutics; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Popa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Department of Clinical Pharmacy; University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d; Cluj-Napoca Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"10.1111\/jcpt.12180-BIB0001|jcpt12180-cit-0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/14779072.6.4.471","article-title":"\u03b2-blockers in the management of hypertension: focus on nebivolol","volume":"6","author":"Wojciechowski","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1111\/jcpt.12180-BIB0002|jcpt12180-cit-0002","first-page":"909","article-title":"A review of the safety and efficacy of nebivolol in the mildly hypertensive patient","volume":"3","author":"Cockcroft","year":"2007","journal-title":"J Vasc Health Risk Manag"},{"key":"10.1111\/jcpt.12180-BIB0003|jcpt12180-cit-0003","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2165\/00003495-200666100-00007","article-title":"Nebivolol: a review of its use in the management of hypertension and chronic heart failure","volume":"66","author":"Moen","year":"2006","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12180-BIB0004|jcpt12180-cit-0004","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2146\/ajhp070459","article-title":"Nebivolol: a new antihypertensive agent","volume":"65","author":"Gray","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/jcpt.12180-BIB0005|jcpt12180-cit-0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CPP44344","article-title":"Nebivolol: a review of its clinical and pharmacological characteristics","volume":"44","author":"Gielen","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12180-BIB0006|jcpt12180-cit-0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/1120274-000000000-00000","article-title":"Nebivolol in the treatment of hypertension in the US","volume":"9","author":"Baldwin","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1111\/jcpt.12180-BIB0007|jcpt12180-cit-0007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/vhrm.2006.2.3.303","article-title":"Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation","volume":"2","author":"Weiss","year":"2006","journal-title":"J Vasc Health Risk Manag"},{"key":"10.1111\/jcpt.12180-BIB0008|jcpt12180-cit-0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11530710-000000000-00000","article-title":"Nebivolol: haemodynamic effects and clinical significance of combined \u03b2-blockade and nitric oxide release","volume":"70","author":"Kamp","year":"2010","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12180-BIB0009|jcpt12180-cit-0009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1755-5922.2008.00054.x","article-title":"Nebivolol: a highly selective \u03b21-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide","volume":"26","author":"Gupta","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/jcpt.12180-BIB0010|jcpt12180-cit-0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/VHRM.S20669","article-title":"Nebivolol: impact on cardiac and endothelial function and clinical utility","volume":"8","author":"Tobbli","year":"2012","journal-title":"J Vasc Health Risk Manag"},{"key":"10.1111\/jcpt.12180-BIB0011|jcpt12180-cit-0011","first-page":"647","article-title":"Nebivolol in the treatment of chronic heart failure","volume":"3","author":"Veverka","year":"2007","journal-title":"J Vasc Health Risk Manag"},{"key":"10.1111\/jcpt.12180-BIB0012|jcpt12180-cit-0012","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clinthera.2009.03.007","article-title":"Nebivolol: a third-generation \u03b2-blocker for hypertension","volume":"31","author":"Cheng","year":"2009","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12180-BIB0013|jcpt12180-cit-0013","first-page":"188","article-title":"Nebivolol (Bystolic), a novel beta blocker for hypertension","volume":"34","author":"Hilas","year":"2009","journal-title":"P T"},{"key":"10.1111\/jcpt.12180-BIB0014|jcpt12180-cit-0014","first-page":"577","article-title":"Nebivolol - pharmacological aspects","volume":"2","author":"Sahana","year":"2011","journal-title":"Int J Biol Med Res"},{"key":"10.1111\/jcpt.12180-BIB0015|jcpt12180-cit-0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00003495-200262040-00010","article-title":"Paroxetine. an update of its use in psychiatric disorders in adults","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12180-BIB0016|jcpt12180-cit-0016","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00023210-200216060-00006","article-title":"Spotlight on paroxetine in psychiatric disorders in adults","volume":"16","author":"Wagstaff","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1111\/jcpt.12180-BIB0017|jcpt12180-cit-0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003495-199855010-00007","article-title":"Paroxetine: an update of its pharmacology and therapeutic use in depression and a review of its use in other disorders","volume":"55","author":"Gunasekara","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12180-BIB0018|jcpt12180-cit-0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14656566.2012.652085","article-title":"Paroxetine for the treatment of depression: a critical update","volume":"13","author":"Gibiino","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/jcpt.12180-BIB0019|jcpt12180-cit-0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-199834040-00002","article-title":"Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications","volume":"34","author":"Caccia","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12180-BIB0020|jcpt12180-cit-0020","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update","volume":"30","author":"Spina","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12180-BIB0021|jcpt12180-cit-0021","first-page":"P38","article-title":"Effect of chronic administration of fluoxetine on the pharmacokinetics of nebivolol [abstract]","volume":"77","author":"Shaw","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12180-BIB0022|jcpt12180-cit-0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2125.1997.54212.x","article-title":"A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine","volume":"43","author":"Kamali","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12180-BIB0023|jcpt12180-cit-0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mcp.2000.104788","article-title":"Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers","volume":"67","author":"Hemeryck","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12180-BIB0024|jcpt12180-cit-0024","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1592\/phco.31.7.630","article-title":"Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol","volume":"31","author":"Parker","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12180-BIB0025|jcpt12180-cit-0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0091270010365559","article-title":"The influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine","volume":"51","author":"Stout","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12180-BIB0026|jcpt12180-cit-0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1074248410372926","article-title":"The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics","volume":"15","author":"Stout","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/jcpt.12180-BIB0027|jcpt12180-cit-0027","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0091270010370846","article-title":"Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studies","volume":"51","author":"Lindamood","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12180-BIB0028|jcpt12180-cit-0028","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1388-9842(03)00054-0","article-title":"\u03b2-Blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol","volume":"5","author":"Nodari","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12180-BIB0029|jcpt12180-cit-0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08038020410016548","article-title":"Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients","volume":"13","author":"Zanchetti","year":"2004","journal-title":"Blood Press"},{"key":"10.1111\/jcpt.12180-BIB0030|jcpt12180-cit-0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.jhh.1001257","article-title":"Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients","volume":"15","author":"Predel","year":"2001","journal-title":"J Hum Hypertens"},{"key":"10.1111\/jcpt.12180-BIB0031|jcpt12180-cit-0031","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s002280050217","article-title":"Pharmacological properties of nebivolol in man","volume":"51","author":"Bortel","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12180-BIB0032|jcpt12180-cit-0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000093060","article-title":"Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol","volume":"106","author":"Stoschitzky","year":"2006","journal-title":"Cardiology"},{"key":"10.1111\/jcpt.12180-BIB0033|jcpt12180-cit-0033","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1007760515117","article-title":"Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure","volume":"12","author":"Nueten","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/jcpt.12180-BIB0034|jcpt12180-cit-0034","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003495-199957040-00011","article-title":"Nebivolol in the management of essential hypertension: a review","volume":"57","author":"McNeely","year":"1999","journal-title":"Drugs"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12180","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12180\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:28Z","timestamp":1671818728000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12180","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}